Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This phase II trial compares the effect of folate receptor alpha dendritic cells (FRαDCs) to placebo in treating patients with stage III or IV ovarian, fallopian tube or primary peritoneal cancer. FRαDCs, a dendritic cell vaccine, is made from a person's white blood cells. The white blood cells are treated in the laboratory to make dendritic cells (a type of immune cell) mixed with folate receptor alpha (FRalpha), a protein found in high levels on ovarian tumor cells. FRαDCs work by boosting the
Sponsor: Mayo Clinic
Check if you qualify for this ovarian cancer clinical trial in Scottsdale, AZ
If you're searching for ovarian cancer treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.